ClinicalTrials.gg
Drug

Avalglucosidase alfa clinical trials

Also written GZ402666 and Nexviazyme.

studies test it
10
open now
1
in phase 3
2
first study started
2001

How each study uses avalglucosidase alfa is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the avalglucosidase alfa studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
6 Aug 2021 · NEXVIAZYME · BLA 761194 (FDA, Drugs@FDA)
European Union
24 Jun 2022 · Nexviadyme · EMEA/H/C/005501 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Avalglucosidase Alfa
4
Avalglucosidase alfa (GZ402666)
3

Brand

Nexviazyme
2

Development codes

GZ402666
4

Other names

neoGAA
1

Studies by the year they started

10 studies that test it; most in 2022 (2)

Studies that test avalglucosidase alfa, by start year
YearStudies
20011
20111
20131
20141
20161
20171
20211
20222
20251

By phase

A phase 1/2 study counts in both.

Phase 1
1
Phase 2
4
Phase 3
2
Phase 4
3

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 9 · Other 1

Genzyme, a Sanofi Company (7) · Iris Plug (1) · Sanofi (1) · Amicus Therapeutics (1)

Often tested with

Tested in the same studies.

Duvoglustat (1) · Alglucosidase alfa (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 1

Studies that test avalglucosidase alfa.

Studies

Open first, then newest update. How each study uses avalglucosidase alfa is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 10

Given beside what is tested · 1 — avalglucosidase alfa is usual care or a partner of the new treatment

Codes

What other systems call avalglucosidase alfa · ClinicalTrials.gg INT002184

  • MeSH (NLM) C000731975avalglucosidase alfaOne source NLM
  • UNII (FDA) EO144CP0X9AVALGLUCOSIDASE ALFAConfirmed FDA, NLM, Wikidata
  • RxNorm 2565814One source FDA
  • Wikidata Q107693067avalglucosidase alfaConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C169795Avalglucosidase AlfaOne source FDA
  • DrugBank DB16099One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.